Thoroughbred Financial Services’s Recursion Pharmaceuticals RXRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-10,000	Closed	-$67K	–	716
2024 Q4	$67K	Sell	10,000 -5,000	-33%	-$33.5K	﹤0.01%	679
2024 Q3	$98K	Buy	+15,000	New	+$98K	0.01%	643